74.90
price up icon2.39%   1.75
after-market アフターアワーズ: 75.05 0.15 +0.20%
loading
前日終値:
$73.15
開ける:
$73.15
24時間の取引高:
1.57M
Relative Volume:
1.41
時価総額:
$2.53B
収益:
$55.63M
当期純損益:
$-158.10M
株価収益率:
-8.8953
EPS:
-8.4202
ネットキャッシュフロー:
$-203.94M
1週間 パフォーマンス:
+7.29%
1か月 パフォーマンス:
+30.67%
6か月 パフォーマンス:
+72.14%
1年 パフォーマンス:
+219.13%
1日の値動き範囲:
Value
$73.15
$77.23
1週間の範囲:
Value
$63.89
$77.23
52週間の値動き範囲:
Value
$21.02
$109.00

Nektar Therapeutics Stock (NKTR) Company Profile

Name
名前
Nektar Therapeutics
Name
セクター
Healthcare (1094)
Name
電話
(415) 482-5300
Name
住所
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA
Name
職員
63
Name
Twitter
@nektarnews
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
NKTR's Discussions on Twitter

Compare NKTR vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
NKTR icon
NKTR
Nektar Therapeutics
74.90 2.47B 55.63M -158.10M -203.94M -8.4202
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
522.25 134.41B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
676.23 68.13B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
919.94 57.01B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
321.59 41.79B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
190.46 40.39B 742.00K -1.37B -1.07B -7.0731

Nektar Therapeutics Stock (NKTR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-24 開始されました Wedbush Neutral
2026-03-17 開始されました TD Cowen Buy
2026-02-10 アップグレード William Blair Mkt Perform → Outperform
2025-11-26 開始されました Citigroup Buy
2025-06-24 繰り返されました BTIG Research Buy
2025-06-24 繰り返されました H.C. Wainwright Buy
2025-04-11 アップグレード Jefferies Hold → Buy
2025-03-14 アップグレード Oppenheimer Perform → Outperform
2025-01-08 開始されました B. Riley Securities Buy
2024-12-10 開始されました H.C. Wainwright Buy
2024-11-04 開始されました Piper Sandler Overweight
2024-09-30 再開されました BTIG Research Buy
2024-06-28 開始されました Rodman & Renshaw Buy
2023-11-20 再開されました JP Morgan Underweight
2023-11-09 アップグレード TD Cowen Market Perform → Outperform
2023-05-10 アップグレード Jefferies Underperform → Hold
2023-02-24 ダウングレード Jefferies Hold → Underperform
2022-08-08 ダウングレード JP Morgan Neutral → Underweight
2022-05-31 再開されました Jefferies Hold
2022-04-18 ダウングレード Goldman Neutral → Sell
2022-03-15 ダウングレード Cowen Outperform → Market Perform
2022-03-15 ダウングレード Mizuho Buy → Neutral
2022-03-14 ダウングレード BTIG Research Buy → Neutral
2022-03-14 ダウングレード BofA Securities Neutral → Underperform
2022-03-14 ダウングレード Stifel Buy → Hold
2022-03-14 ダウングレード William Blair Outperform → Mkt Perform
2022-03-09 アップグレード Oppenheimer Perform → Outperform
2021-11-08 アップグレード The Benchmark Company Hold → Buy
2021-09-10 開始されました BofA Securities Neutral
2021-06-28 アップグレード Stifel Hold → Buy
2021-05-18 再開されました Goldman Neutral
2021-02-22 ダウングレード The Benchmark Company Buy → Hold
2021-01-06 開始されました Stifel Hold
2020-09-14 開始されました JP Morgan Neutral
2020-06-10 ダウングレード CFRA Hold → Sell
2020-05-12 繰り返されました H.C. Wainwright Neutral
2020-04-22 開始されました The Benchmark Company Buy
2020-03-30 アップグレード Goldman Sell → Neutral
2020-03-04 開始されました Barclays Overweight
2020-02-03 アップグレード Mizuho Neutral → Buy
2019-10-24 開始されました Oppenheimer Perform
2019-10-08 ダウングレード Goldman Buy → Sell
2019-08-09 ダウングレード JP Morgan Overweight → Neutral
2019-08-09 ダウングレード Jefferies Buy → Hold
2019-08-09 ダウングレード Mizuho Buy → Neutral
2019-03-15 開始されました SVB Leerink Mkt Perform
2018-12-13 開始されました Goldman Buy
2018-06-11 ダウングレード H.C. Wainwright Buy → Neutral
2018-06-04 繰り返されました H.C. Wainwright Buy
2018-04-20 開始されました Seaport Global Securities Buy
2018-04-13 再開されました Piper Jaffray Overweight
2018-04-06 繰り返されました Mizuho Buy
2018-04-02 再開されました H.C. Wainwright Buy
すべてを表示

Nektar Therapeutics (NKTR) 最新ニュース

pulisher
Jul 05, 2026

Nektar Therapeutics (NKTR) Advances Autoimmune Pipeline, Is The Upside Already Priced In? - simplywall.st

Jul 05, 2026
pulisher
Jul 05, 2026

NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results - Stocktwits

Jul 05, 2026
pulisher
Jul 04, 2026

NKTR Stock Clocks Best Day In Over 2 Months As Investors Await Upcoming Clinical Data In Eczema - Stocktwits

Jul 04, 2026
pulisher
Jul 02, 2026

Insider Sell: Jonathan Zalevsky Sells Shares of Nektar Therapeutics (NKTR) - GuruFocus

Jul 02, 2026
pulisher
Jul 02, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nektar Therapeutics (NKTR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jul 02, 2026
pulisher
Jul 02, 2026

Nektar Therapeutics R&D chief sells $397,670 of common stock - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Form 4 Nektar Therapeutics For: 2 July By Investing.com - Investing.com Nigeria

Jul 02, 2026
pulisher
Jul 02, 2026

Nektar Therapeutics R&D chief sells $397,670 of common stock By Investing.com - Investing.com UK

Jul 02, 2026
pulisher
Jul 02, 2026

Nektar Therapeutics Stock Climbs As Immunology Sentiment Improves - timothysykes.com

Jul 02, 2026
pulisher
Jul 02, 2026

How Nektar Therapeutics’ Broad FTSE Russell Index Inclusion Will Impact Nektar Therapeutics (NKTR) Investors - simplywall.st

Jul 02, 2026
pulisher
Jun 30, 2026

Jonathan Zalevsky (NKTR) sells 5,737 shares via 10b5-1 plan - Stock Titan

Jun 30, 2026
pulisher
Jun 30, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Nektar Therapeutics (NKTR) Investors to Inquire about Securities Investigation - ACCESS Newswire

Jun 30, 2026
pulisher
Jun 30, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nektar Therap - The National Law Review

Jun 30, 2026
pulisher
Jun 29, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nektar Therapeutics (NKTR) And Encourages Investors to Reach Out - ACCESS Newswire

Jun 29, 2026
pulisher
Jun 29, 2026

Nektar Therapeutics(NasdaqCM:NKTR) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Nektar Therapeutics(NasdaqCM: NKTR) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Nektar Therapeutics(NasdaqCM: NKTR) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Nektar Therapeutics(NasdaqCM: NKTR) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Nektar Therapeutics(NasdaqCM: NKTR) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Nektar Therapeutics(NasdaqCM: NKTR) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Nektar Therapeutics(NasdaqCM: NKTR) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Nektar Therapeutics(NasdaqCM: NKTR) added to Russell 3000 Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Nektar Therapeutics Actuals & Estimates (NASDAQ:NKTR) - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Nektar Therapeutics(NasdaqCM: NKTR) added to Russell 3000 Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 27, 2026

Price to sales forward of Nektar Therapeutics – SWB:ITH0 - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listi - GuruFocus

Jun 26, 2026
pulisher
Jun 26, 2026

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Jun 26, 2026
pulisher
Jun 26, 2026

Price to earnings forward of Nektar Therapeutics – NASDAQ:NKTR - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to EBITDA forward of Nektar Therapeutics – DUS:ITH0 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to book forward of Nektar Therapeutics – NASDAQ:NKTR - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to EBIT forward of Nektar Therapeutics – DUS:ITH0 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to revenue forward of Nektar Therapeutics – NASDAQ:NKTR - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nektar Therapeutics (NKTR) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of Nektar Therapeutics – DUS:ITH0 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Nektar Therapeutics Company Profile & Introduction - Moomoo

Jun 25, 2026
pulisher
Jun 25, 2026

NKTR Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

A419UB Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

What a $1.2 Million Insider Sale Means for Nektar With Shares Up 160% This Past Year - AOL.com

Jun 25, 2026
pulisher
Jun 23, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nektar Therapeutics (NKTR) And Encourages Stockholders to Connect - ACCESS Newswire

Jun 23, 2026
pulisher
Jun 23, 2026

2026-06-23 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Nektar Therapeutics (NKTR) And Encourages Stockholders to Connect | NDAQ:NKTR | Press Release - Stockhouse

Jun 23, 2026
pulisher
Jun 23, 2026

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal - Yahoo Finance

Jun 23, 2026
pulisher
Jun 23, 2026

Nektar Therapeutics (NKTR) Institutional Confidence - TradingKey

Jun 23, 2026
pulisher
Jun 23, 2026

Nektar Therapeutics chief R&D officer sells $336,211 in stock - Investing.com UK

Jun 23, 2026
pulisher
Jun 22, 2026

Nektar Therapeutics chief R&D officer sells $336,211 in stock By Investing.com - Investing.com Nigeria

Jun 22, 2026
pulisher
Jun 22, 2026

Form 4 Nektar Therapeutics For: 22 June By Investing.com - Investing.com South Africa

Jun 22, 2026
pulisher
Jun 21, 2026

Nektar Therapeutics (NKTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 21, 2026
pulisher
Jun 21, 2026

2026-06-21 | Nektar Therapeutics (NKTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:NKTR | Press Release - Stockhouse

Jun 21, 2026
pulisher
Jun 20, 2026

Certain Performance Restricted Stock Units of Nektar Therapeutics are subject to a Lock-Up Agreement Ending on 21-JUN-2026. - marketscreener.com

Jun 20, 2026
pulisher
Jun 20, 2026

Certain Restricted Stock Units of Nektar Therapeutics are subject to a Lock-Up Agreement Ending on 21-JUN-2026. - marketscreener.com

Jun 20, 2026
pulisher
Jun 20, 2026

Certain Common Stock of Nektar Therapeutics are subject to a Lock-Up Agreement Ending on 21-JUN-2026. - marketscreener.com

Jun 20, 2026
pulisher
Jun 20, 2026

NKTR Technical Analysis & Stock Price Forecast - Intellectia AI

Jun 20, 2026

Nektar Therapeutics (NKTR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$112.84
price up icon 1.17%
$57.80
price up icon 1.55%
$36.31
price up icon 2.60%
$79.77
price down icon 2.48%
ONC ONC
$308.96
price down icon 0.16%
$190.46
price up icon 0.25%
大文字化:     |  ボリューム (24 時間):